Site deployment services for MHS genesis at wave 1 sites in northern california.

Ended Awarded Last action

Contract number
HT003819F0002
Awardee
Awarding agency
Obligated
$14,345,155

Award facts

Contract value 91% obligated
$15,799,951.97 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price Incentive
Place of performance
Reston, VA 20190, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 · MHS genesis support services -$975,538
Other Administrative Action P00007 · Site deployment of MHS genesis electronic health record to facilities in the northwest united states. -$793,278
Other Administrative Action P00006 · Site deployment of MHS genesis at military treatment facilities located in states such as idaho and california. $0
Other Administrative Action P00005 · MHS genesis site deployment activities to support identified sites in the northwest as well as national guard and reserve. $0
Other Administrative Action P00004 · Site deployment activities for MHS genesis. $887,448
Other Administrative Action P00003 · Site deployment for MHS genesis at military treatment facilities. $0
Other Administrative Action P00002 · Site deployment activities for MHS genesis wave 1. $5,031,126
Other Administrative Action P00001 · Site deployment activities for deployment of MHS genesis to wave 1 sites. $0
Original award $10,195,397

About this award

The U.S. Defense Health Agency awarded Leidos, Inc. a $15,799,951.97 fixed-price incentive delivery order contract to provide site deployment services for the MHS GENESIS electronic health record system at Wave 1 sites in Northern California. This work is being performed under Leidos' Leidos Integration Operating Segment Division, doing business as SAIC. Leidos is a large, established government contractor that has been awarded numerous prime and subcontracts across various federal agencies. The contract does not have a set-aside designation. Leidos Holdings, Inc. is the parent company of Leidos, Inc.

Quick answers

Who was awarded contract HT003819F0002?

HT003819F0002 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on October 30, 2018.

How much is contract HT003819F0002 worth?

The government has obligated $14,345,155 on HT003819F0002. Its current value, with exercised options, is $15,799,952.

Is contract HT003819F0002 an order under another contract?

Yes. HT003819F0002 is a delivery order under N0003915D0044, an indefinite delivery contract.

Was contract HT003819F0002 competed?

The extent of competition for HT003819F0002 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award